Homocysteinemia, hypertension, and family history of diabetes in a smoking male population in Saudi Arabia
Author:
Al-Daghri Nasser1, Al-Attas Omar1
Affiliation:
1. 1Biochemistry Department, King Saud University College of Science, P.O Box 2455, Riyadh, 11451, Kingdom of Saudi Arabia
Abstract
AbstractArabs have a lower incidence of atherosclerosis than other ethnicities, but few studies have examined homocysteine (HCYS) as a risk factor for cardiovascular disease in this population. Here, we investigated the association between serum HYCS levels and risk factors for cardiovascular disease (smoking, hypertension, and family history of diabetes) in Saudi males. A total of 50 smokers and 72 nonsmokers completed a general health questionnaire. In addition, their lipid profiles were measured using routine methods and HCYS levels by high-performance liquid chromatograph with electrochemical detection. Regression analysis showed negative associations between HCYS and glucose (r = −0.22; P < 0.05) as well as family history of diabetes (r = −0.21; P < 0.05). HCYS levels were similar between hypertensive and nonhypertensive smokers, but they were significantly elevated in hypertensive nonsmokers (P = 0.027) and lower in smokers with family history of diabetes (P = 0.01). Levels of HCYS among nonsmokers inversely correlated with history of diabetes and elevated glucose. Nonsmokers’ HCYS levels were significantly elevated in the presence of hypertension and correlated with diastolic blood pressure. Thus, HCYS may be a predictor of hypertension among nonsmokers. Until further trials are conducted, we recommend vitamin B6/folic acid supplementation for the Saudi hypertensive population as an adjuvant therapy.
Publisher
Walter de Gruyter GmbH
Reference35 articles.
1. Bleie O., Semb A.G., Grundt H., Nordrehauq J.E., Vollset S.E., Ueland P.M., et al., Homocysteinelowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease, J. Intern. Med., 2007, 262, 244–253 2. Wierzbicki A.S., Homocysteine and cardiovascular disease: a review of evidence, Diab. Vasc. Dis. Res., 2007, 4, 143–150 3. Signorello M.G., Viviani G.L., Armani U., Cerone R., Minniti G., Piana A. et al., Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus, Thromb. Res., 2007, 120, 607–613 4. Zakai N.A., Katz R., Jenny N.S., Psaty B.M., Reiner A.P., Schwartz S.M., et al., Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study, J. Thromb. Haemost., 2007, 5, 1125–1127 5. Gonzales S., Huerta J.M., Fernandez S., Patterson A.M., Laceras C., Homocysteine increases the risk of mortality in elderly individuals, Br. J. Nutr., 2007, 97, 1128–1135
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|